Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony C Faber

Showing results (11-20 of 71) with videos related to

Pageof 8
Sort By:
Cancer Research|January 5, 2020
Investigating New Mechanisms of Acquired Resistance to Targeted Therapies: If You Hit Them Harder, Do They Get Up Differently?Konstantinos V Floros, Aaron N Hata, Anthony C Faber
Advances in Pharmacology (San Diego, Calif.)|September 11, 2012
Apoptosis in targeted therapy responses: the role of BIMAnthony C Faber, Hiromichi Ebi, Carlotta Costa, et al.
Cancer Science|March 12, 2014
Not just gRASping at flaws: finding vulnerabilities to develop novel therapies for treating KRAS mutant cancersHiromichi Ebi, Anthony C Faber, Jeffrey A Engelman, et al.
Cancer Research|March 4, 2025
A Critical Appraisal of the Utility of Targeting Therapy-Induced Senescence for Cancer TreatmentTareq Saleh, Edward F Greenberg, Anthony C Faber, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|June 8, 2019
Paragangliomas in Carney-Stratakis SyndromeArushi Khurana, Lin Mei, Anthony C Faber, et al.
Endocrine-Related Cancer|November 25, 2017
Classification of gastrointestinal stromal tumor syndromesPriya Gopie, Lin Mei, Anthony C Faber, et al.
Biochemical Pharmacology|September 19, 2006
Inhibition of phosphatidylinositol 3-kinase-mediated glucose metabolism coincides with resveratrol-induced cell cycle arrest in human diffuse large B-cell lymphomasAnthony C Faber, Fay J Dufort, Derek Blair, et al.
Journal of Lipid Research|February 22, 2008
Thematic review series: sphingolipids. Ganglioside GM3 suppresses the proangiogenic effects of vascular endothelial growth factor and ganglioside GD1aPurna Mukherjee, Anthony C Faber, Laura M Shelton, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|April 25, 2025
Myc family proteins: Molecular drivers of tumorigenesis and resistance in neuroendocrine tumorsHannah M Hylton-McComas, Alyssa Cordes, Konstantinos V Floros, et al.
Trends in Cancer|February 8, 2018
Gastrointestinal Stromal Tumors: The GIST of Precision MedicineLin Mei, Steven C Smith, Anthony C Faber, et al.
Pageof 8

Showing results (11-20 of 71) with videos related to

Sort By:
Pageof 8
Cancer Research|January 5, 2020
Investigating New Mechanisms of Acquired Resistance to Targeted Therapies: If You Hit Them Harder, Do They Get Up Differently?Konstantinos V Floros, Aaron N Hata, Anthony C Faber
Advances in Pharmacology (San Diego, Calif.)|September 11, 2012
Apoptosis in targeted therapy responses: the role of BIMAnthony C Faber, Hiromichi Ebi, Carlotta Costa, et al.
Cancer Science|March 12, 2014
Not just gRASping at flaws: finding vulnerabilities to develop novel therapies for treating KRAS mutant cancersHiromichi Ebi, Anthony C Faber, Jeffrey A Engelman, et al.
Cancer Research|March 4, 2025
A Critical Appraisal of the Utility of Targeting Therapy-Induced Senescence for Cancer TreatmentTareq Saleh, Edward F Greenberg, Anthony C Faber, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|June 8, 2019
Paragangliomas in Carney-Stratakis SyndromeArushi Khurana, Lin Mei, Anthony C Faber, et al.
Endocrine-Related Cancer|November 25, 2017
Classification of gastrointestinal stromal tumor syndromesPriya Gopie, Lin Mei, Anthony C Faber, et al.
Biochemical Pharmacology|September 19, 2006
Inhibition of phosphatidylinositol 3-kinase-mediated glucose metabolism coincides with resveratrol-induced cell cycle arrest in human diffuse large B-cell lymphomasAnthony C Faber, Fay J Dufort, Derek Blair, et al.
Journal of Lipid Research|February 22, 2008
Thematic review series: sphingolipids. Ganglioside GM3 suppresses the proangiogenic effects of vascular endothelial growth factor and ganglioside GD1aPurna Mukherjee, Anthony C Faber, Laura M Shelton, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|April 25, 2025
Myc family proteins: Molecular drivers of tumorigenesis and resistance in neuroendocrine tumorsHannah M Hylton-McComas, Alyssa Cordes, Konstantinos V Floros, et al.
Trends in Cancer|February 8, 2018
Gastrointestinal Stromal Tumors: The GIST of Precision MedicineLin Mei, Steven C Smith, Anthony C Faber, et al.
Pageof 8